NCT05933265
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05933265
Title Study of LP-184 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lantern Pharma Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Arkansas 72758 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Norton Healthcare, Inc. Louisville Kentucky 40205 United States Details
John Hopkins - The Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
UT Health Science Center San Antonio San Antonio Texas 78229 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field